Letters New UK antimicrobial resistance strategy

UK antimicrobial resistance strategy must be set in a wider context

BMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f2999 (Published 15 May 2013) Cite this as: BMJ 2013;346:f2999
  1. Peter M Hawkey, professor of clinical and public health bacteriology1,
  2. Bharat C Patel, consultant medical microbiologist2,
  3. Alexander J Trees, peer3
  1. 1Institute of Microbiology and Infection, University of Birmingham, Birmingham B15 2TT, UK
  2. 2Public Health Laboratory London, Public Health England, Barts Healthcare NHS Trust, Division of Infection, London, UK
  3. 3House of Lords, London, UK
  1. peter.hawkey{at}heartofengland.nhs.uk

We welcome the editorial on the chief medical officer’s intent to tackle the rise of antimicrobial resistance.1 The remarkable success in reducing meticillin resistant Staphylococcus aureus bacteraemia to less than 2% exposes the rapidly growing problem of bacteraemia caused by Gram negative bacteria, particularly Escherichia coli (36%).2 E coli differs from most agents …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe